The transmembrane pressure is determined by the positive pressure applied to the blood and the negative pressure applied to the other side of the membrane. The blood flow through the filter is a function of pressure in the arterial line of the bypass circuit and the resistance of the haemofiltration circuit. A blood flow of 300-500 ml/min through the filter device and a transmembrane pressure of about 300 mm Hg are considered safe and will not cause appreciable haemolysis. 
Haemodialysis and haemofiltration on cardiopulmonary bypass are relatively new techniques. Haemodialysis during cardiopulmonary bypass was first described by Soffer et al in 1979. ' The process requires a dialysate solution and depends on the concentration gradient of solutes across the dialyser membrane. The technique of haemofiltration during cardiopulmonary bypass, first instituted by Darup et al in 1979,2 does not require the flow of a dialysate fluid with its inherent complexities. The driving force for haemofiltration is the pressure gradient across the membrane rather than a concentration gradient as in dialysis.
The transmembrane pressure is determined by the positive pressure applied to the blood and the negative pressure applied to the other side of the membrane. The blood flow through the filter is a function of pressure in the arterial line of the bypass circuit and the resistance of the haemofiltration circuit. A blood flow of 300-500 ml/min through the filter device and a transmembrane pressure of about 300 mm Hg are considered safe and will not cause appreciable haemolysis. These techniques represent a major improvement in the perioperative care of patients with impaired renal function undergoing open heart surgery. In addition to restoring normovolaemia and a normal packed cell volume at the end of the operation, intraoperative dialysis and haemofiltration provide a satisfactory means of controlling the serum potassium concentration.
Patients and methods
From January 1981 to December 1983 haemodialysis and haemofiltration were used during cardiopulmonary bypass in 26 patients (20 men, six women). The mean age was 56 (range 18-72) years. The indications for the use of these techniques are shown in table 1. The surgical procedures included eight valve replacements, three myocardial revascularisations, three combined procedures, and seven orthotopic heart transplantations (table 2) .
Five patients received dialysis during the perfusion period. Dialysis was carried out with a Nephros Allegro dialyser (Organon Teknika-Veedijk 58- Figure 1 illustrates the haemofiltration circuit during bypass. 
Results

PATIENTS WITH ESTABLISHED ENDSTAGE RENAL FAILURE
All five patients with established endstage renal failure (table 3) were having regular haemodialysis. The mean serum potassium concentration immediately after operation was 4-5 mmol(mEq)/l. In three patients the serum potassium concentration started to rise within 24 hours of operation. Intermittent doses of 50% dextrose and insulin with calcium resonium successfully controlled the serum potassium. Excessive fluid retention and rapid rise of blood urea were not encountered in the immediate postoperative period and the patients did not require further dialysis until the third or fourth postoperative day, when they were in a more stable haemodynamic state and could tolerate haemodialysis. The mean blood urea concentration 24 hours after operation was 24-3 mmol/l (146.4 mg/100 ml) (mean preoperative concentration 31D6 mmol/l (190-4 mg/100 ml)).
PATIENTS WITH SECONDARY RENAL IMPAIRMENT
Secondary renal impairment, which was present in 16 cases, was defined arbitrarily as a blood urea concentration higher than 10 mmolIl. Dialysis was used in three patients, where the mean volume of fluid removed was 2160 ml (mean volume of pump prime and additions 2360 ml). Haemofiltration was used in 13 patients. The mean volume of ultrafiltrate was 6860 ml (mean volume of pump prime, additions and replacement 7800 ml). The postoperative serum potassium concentration ranged from 3-5 to 5*1 (mean 4.4) mmolI (mean preoperative concentration 4-3 mmolI1). The mean postoperative urea concentration was 13-4 mmolI (80-7 mg/100 ml) (mean preoperative concentration 16-4 mmolI (98.8 mg/ 100 ml)). Figure 2 shows the perioperative changes in blood urea. There was a rise in blood urea concentration in two patients 24 hours after operation. One of these received a dose of cyclosporin A (a known nephrotoxic drug) before an aborted heart transplantation. Twenty-four hours later he received a second dose of cyclosporin A and heart transplantation was carried out. The second patient, who had multiple congenital defects, was anuric with a steadily rising urea concentration for 24 hours before operation. There were two deaths in this group. One patient, who had had an aortic and mitral valve replacement, returned to the intensive care unit with full inotropic support and balloon counterpulsation. Renal function showed temporary improvement but the patient developed systemic septicaemia and respiratory failure and died four weeks later. The second patient, with multiple congenital defects and hypoplastic right ventricle, died on the second postoperative day from low cardiac output. Mechanical washing and concentration of the red cells with a cell saver is an effective method of haemoconcentration. This technique, however, is a discontinuous method which requires batch processing of the blood. Plasma is lost and the cost of capital and disposable equipment is high. 9 Haemofiltration in parallel with cardiopulmonary bypass, on the other hand, is a simple and effective procedure, which provides the perfusionist with an additional tool to accomplish haemoconcentration. Haemofiltration can be achieved with either purpose designed haemofilters, which tend to be expensive, or high flux dialysers, some of which are almost as efficient at haemofiltration as the purpose designed filters but much cheaper. The limiting factor for the removal of ultrafiltrate during haemofiltration is the membrane pore size and geometry and the surface area. All solutes with a molecular size less than the pore size of the membrane are filtered and those with a larger molecular size are retained (fig 3) . Figure 4 illustrates the clearance rates of various dialysers and haemofilters. By removal of excess fluid normovolaemia and a normal packed cell volume can be restored. Furthermore, plasma protein concentration and plasma osmotic pressure, which are known to be reduced during bypass,'" can be 
